NFE2L2 and diabetic cardiomyopathy: Our previous studies showed that activation of Nrf2 protects the heart against ischemia-reperfusion injury, diabetic cardiomyopathy, and angiotensin II- (Ang II-) induced cardiomyopathy [32–35].